
The cross-Atlantic partnership CARB-X, Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, has announced that it would be funding 11 biotech companies …
Five Facts about cardiovascular disease
Artificial hearts: a century of innovation

